Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Other Working Capital Changes (2017 - 2025)

Catheter Precision (VTAK) has disclosed Other Working Capital Changes for 9 consecutive years, with $58000.0 as the latest value for Q4 2025.

  • Quarterly Other Working Capital Changes rose 159.18% to $58000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$4000.0 through Dec 2025, up 95.96% year-over-year, with the annual reading at -$4000.0 for FY2025, 95.96% up from the prior year.
  • Other Working Capital Changes for Q4 2025 was $58000.0 at Catheter Precision, down from $83000.0 in the prior quarter.
  • The five-year high for Other Working Capital Changes was $685000.0 in Q3 2023, with the low at -$881000.0 in Q4 2023.
  • Average Other Working Capital Changes over 5 years is -$73200.0, with a median of -$68000.0 recorded in 2023.
  • Peak annual rise in Other Working Capital Changes hit 484.52% in 2022, while the deepest fall reached 1081.08% in 2022.
  • Over 5 years, Other Working Capital Changes stood at $84000.0 in 2021, then surged by 484.52% to $491000.0 in 2022, then plummeted by 279.43% to -$881000.0 in 2023, then soared by 88.88% to -$98000.0 in 2024, then skyrocketed by 159.18% to $58000.0 in 2025.
  • According to Business Quant data, Other Working Capital Changes over the past three periods came in at $58000.0, $83000.0, and -$77000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.